Chelation Therapy
Chelation Therapy is a process of detoxifying the body by binding toxic heavy metals (lead, cadmium, mercury, arsenic, aluminum and others) in the body with agents as Ca-EDTA, DMPS and DMSA and excreting them via the urine
Chelation Therapy is used for:
MAKE AN APPOINTMENT
| Weekdays | 9am – 5pm |
OFFICE LOCATION
175 Concourse Boulevard
Santa Rosa, California 95403
TESTIMONIALS
“Great local medical office providing natural, holistic, homeopathic remedies. The staff are all very friendly and helpful. I do my best to come every week for their Vitamin Shot Happy Hour.”
“The whole clinic is astounding, the B12 happy hour is a great resource and helps me to stay alert and healthy. The girls up front are always in good spirits and eager to please. I have referred many friends to the NIMC and they all have thanked me profusely for the recommendation. Based off of my numerous visits to different doctors at the NIMC, I am very confident that you too will find the same value in their expertise as I have.”
“NIMC is what I have been waiting for, for years . . . it really helps. They are on the right track.”
Chelation Therapy
Chelation therapy is used as an adjunct therapy in Cancer treatments as one needs to evaluate the toxic load of a patient and those determinants to one’s immune, neurological and hormonal function in the interaction with cancer.
Chelation therapy is also used with patients with cardiovascular disease, such as atherosclerosis, diabetes and other circulatory diseases. It improves circulation by the removal of accumulated build up (plaques) that damage those vessels.
The study of chelation therapy was funded by the National Heart, Lung and Blood Institute and the National Center for Complementary and Alternative Medicine, from 2003 to 2007. The results of the study, published in the March 27, 2013 issue of the Journal of the America Medical Association (JAMA), found that patients who received chelation therapy had 18% fewer cardiovascular events defined as death, heart attack, stroke, coronary revascularization, and hospitalizations for angina compared to placebo. Diabetics appeared to particularly benefit, with a 39% reduction in cardiac events.
Dr. Goldberg worked at a satellite clinic in Napa, Califronia, where this study was performed and administered therapies as part of this study!!
The results are encouraging and hopefully will lead to further evaluation of chelation therapy as a useful adjunct in the management of cardiovascular disease.